The Impact of Community Pharmacist-Led Population Health Initiatives On Chronic Disease Management and Healthcare Utilization Reduction in Rural Communities

References

[1] Bingham, J. M., Black, M., Anderson, E. J., Reignier, T., Stoffel, R. T., Tonyan, J., Stanislaw, J., Marupuru, S., & Axon, D. R. (2021). Impact of telehealth interventions on medication adherence for patients with type 2 diabetes, hypertension, and/or dyslipidemia: A systematic review. Annals of Pharmacotherapy, 55(5), 637–649. https://doi.org/10.1177/1060028020950726

[2] Como, M., Carter, C. W., Larose-Pierre, M., O’Dare, K., Hall, C. R., Mobley, J., Robertson, G., Leonard, J., & Tew, L. (2020). Pharmacist-led chronic care management for medically underserved rural populations in Florida during the COVID-19 pandemic. Preventing Chronic Disease, 17, E74. https://doi.org/10.5888/pcd17.200265

[3] DeBoer, T., Kopfhamer, R., Kellar, C., Lee, J., Nichols, K., & Griesbach, S. (2021). Impact of a pharmacist-led comprehensive medication management program in patients with diabetes in a rural health care setting. Journal of the Pharmacy Society of Wisconsin, 24(1), 14–19.

[4] Greer, N., Bolduc, J., Geurkink, E., Rector, T., Olson, K., Koeller, E., Fortunato, G., & Wilt, T. J. (2016). Pharmacist-led chronic disease management: A systematic review of effectiveness and harms compared with usual care. Annals of Internal Medicine, 165(1), 30–40. https://doi.org/10.7326/M15-3058

[5] Haynes, K. T., Oberne, A., Cawley, M., & Matulewicz, R. (2011). Effectiveness of a pharmacist-led cardiovascular risk reduction clinic in rural Perry County, Alabama. Preventing Chronic Disease, 8(6), A134. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4976181/

[6] Jacob, V., Reynolds, J. A., Chattopadhyay, S. K., Hopkins, D. P., & Clymer, J. M. (2022). Pharmacist interventions for medication adherence: Community guide economic reviews for cardiovascular disease. American Journal of Preventive Medicine, 62(3), e202–e222. https://doi.org/10.1016/j.amepre.2021.07.007

[7] Kelly, W. N., Ho, M. J., Smith, T., Bullers, K., & Kumar, A. (2023). Association of pharmacist intervention counseling with medication adherence and quality of life: A systematic review and meta-analysis of randomized trials. Journal of the American Pharmacists Association, 63(4), 1095–1105. https://doi.org/10.1016/j.japh.2023.04.024

[8] Korcegez, E. I., Sancar, M., & Demirtunc, R. (2017). Effect of a pharmacist-led program on improving outcomes in patients with type 2 diabetes mellitus from northern Cyprus: A randomized controlled trial. Journal of Managed Care & Specialty Pharmacy, 23(5), 573–582. https://doi.org/10.18553/jmcp.2017.23.5.573

[9] Lounsbery, J. L., Green, C. G., Bennett, M. S., & Pedersen, C. A. (2009). Evaluation of pharmacists’ barriers to the implementation of medication therapy management services. Journal of the American Pharmacists Association, 49(1), 51–58. https://doi.org/10.1331/JAPhA.2009.07183

[10] Makhinova, T., Johnson, J. A., Minhas-Sandhu, J. K., Necyk, C., Bhutani, M., & Eurich, D. T. (2023). Pharmacists’ chronic disease management in chronic obstructive pulmonary disease: Effect on health services utilization. Journal of Managed Care & Specialty Pharmacy, 29(6), 671–679. https://doi.org/10.18553/jmcp.2023.29.6.671

[11] Matzke, G. R., Moczygemba, L. R., Williams, K. J., Czar, M. J., & Lee, W. T. (2018). Impact of a pharmacist-physician collaborative care model on patient outcomes and health services utilization. American Journal of Health-System Pharmacy, 75(14), 1039–1047. https://doi.org/10.2146/ajhp160789

[12] Nguyen, E., Gavrilyuk, O., Collins, J. C., Hughes, J. D., & Hoti, K. (2023). Pharmacist-led interventions for medication adherence in patients with chronic kidney disease: A scoping review. Pharmacy, 11(6), 185. https://doi.org/10.3390/pharmacy11060185

[13] Omboni, S., & Caserini, M. (2018). Effectiveness of pharmacist’s intervention in the management of cardiovascular diseases. Open Heart, 5(1), e000687. https://doi.org/10.1136/openhrt-2017-000687

[14] Pande, S., Hiller, J. E., Nkansah, N., & Bero, L. (2013). The effect of pharmacist-provided non-dispensing services on patient outcomes, health service utilisation and costs in low- and middle-income countries. Cochrane Database of Systematic Reviews, 2, CD010398. https://doi.org/10.1002/14651858.CD010398

[15] Ramalho de Oliveira, D., Brummel, A. R., & Miller, D. B. (2010). Medication therapy management: 10 years of experience in a large integrated health care system. Journal of Managed Care Pharmacy, 16(3), 185–195. https://doi.org/10.18553/jmcp.2010.16.3.185

[16] Redmond, P., Grimes, T. C., McDonnell, R., Boland, F., Hughes, C., & Fahey, T. (2018). Impact of medication reconciliation for improving transitions of care. Cochrane Database of Systematic Reviews, 8, CD010791. https://doi.org/10.1002/14651858.CD010791.pub2

[17] Sherry, S. T., Stockbridge, E. L., & Munn, M. B. (2022). Rural community pharmacists’ perceptions of implementing mental health interventions to reach underserved populations. Rural Mental Health, 47(2), 90–99. https://doi.org/10.1037/rmh0000220

[18] Steed, L., Sohanpal, R., Todd, A., Madurasinghe, V. W., Edwards, E. A., Summerbell, C. D., Walton, R. T., & Michie, S. (2019). Community pharmacy interventions for health promotion: Effects on professional practice and health outcomes. Cochrane Database of Systematic Reviews, 12, CD011207. https://doi.org/10.1002/14651858.CD011207.pub2

[19] Warholak, T. L., Menhart, S., El-Ibiary, S., Hincapie, A. L., Rilling, M., & Campbell, P. (2019). Impact evaluation of a four-year academic-community partnership in provision of medication management and tertiary prevention services for rural patients with diabetes and/or hypertension. Journal of the American Pharmacists Association, 60(1), 80–88. https://doi.org/10.1016/j.japh.2019.09.010

[20] Yao, D., Siminerio, L., Zgibor, J. C., Solano, F. X., & Piatt, G. A. (2018). Evaluation of diabetes education and pharmacist interventions in a rural, primary care setting. The Diabetes Educator, 44(1), 55–65. https://doi.org/10.1177/0145721717747648

@article{1719515,
      author = {Harry S Patel},
      title = {The Impact of Community Pharmacist-Led Population Health Initiatives On Chronic Disease Management and Healthcare Utilization Reduction in Rural Communities},
      journal = {Iconic Research And Engineering Journals},
      year = {2025},
      volume = {9},
      number = {5},
      pages = {2866-2879},
      issn = {2456-8880},
      url = {https://www.irejournals.com/formatedpaper/1719515.pdf},
      abstract = {Background: Although rural communities are disproportionately affected by chronic disease, they are also clearly suffering from the chronic shortage of health-care providers. Community pharmacists are increasingly being recruited as key stakeholders to lead population health initiatives as they serve as the most accessible health care access points in many rural communities, but the scope of these initiatives, their impact on chronic disease care and health utilization has not been comprehensively understood and mapped.
Objective: To bring together the latest available evidence to explore, define and synthesise contemporary community pharmacist led population health initiatives in rural areas, their mechanisms, and the potential health-economic, health system and humanistic outcomes, including health-care utilization and cost.
Methods: A systematic review was performed using a scoping framework developed by Arksey and O'Malley and reporting standards recommended in the PRISMA-ScR guidelines, which included mapping peer-reviewed literature up to and including 2024 into systematic reviews, economic analyses, randomised trials and rural programme evaluations. Twenty sources are charted, with the setting, the type of interventions and the mechanisms and the outcome domain.
Results: Pharmacist-led initiatives were grouped (medication therapy management, telehealth and telepharmacy, screening and risk reduction, and collaborative care). In these, interventions were shown to impact positively on adherence to medication, disease control, and quality of life and a slowly expanding and body of evidence were used to show relationships with reduced health-service usage and positive health-economic effects. Reimbursement, staffing and infrastructure issues specific to rural practice influenced implementation.
Conclusion: Community pharmacists can effectively be utilised as part of a viable and viable approach towards underpinning rural chronic disease management and reducing the burdens facing rural health systems. They can only be realized if they receive a flexible and sustainable reimbursement, receive investment in a telepharmacy infrastructure, and get consistent measurement of utilization and cost outcomes.},
      month = {November},
      doi = {https://doi.org/10.64388/IREV9I5-1719515}
  }